4UBI:XETRA:XETRA-UBS (Irl) ETF plc - MSCI USA Socially Responsible UCITS ETF (USD) A-acc (EUR)

ETF | Others |

Last Closing

USD 17.35

Change

0.00 (0.00)%

Market Cap

USD 0.37B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.17 (+0.33%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.28%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.47%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.07 (+0.25%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.12 (-0.47%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.07%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.18 (+0.34%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.60 (+0.59%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.00 (+0.52%)

USD 80.38B

ETFs Containing 4UBI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.07% 80% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.07% 79% B- 77% C+
Trailing 12 Months  
Capital Gain 19.21% 77% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.21% 77% C+ 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.97% 68% D+ 66% D+
Dividend Return 8.97% 67% D+ 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.62% 53% F 62% D
Risk Adjusted Return 77.17% 80% B- 82% B
Market Capitalization 0.37B 59% D- 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike